[go: up one dir, main page]

AU2901997A - Immunogenic complex, use, method of preparation thereof and vaccine containing same - Google Patents

Immunogenic complex, use, method of preparation thereof and vaccine containing same

Info

Publication number
AU2901997A
AU2901997A AU29019/97A AU2901997A AU2901997A AU 2901997 A AU2901997 A AU 2901997A AU 29019/97 A AU29019/97 A AU 29019/97A AU 2901997 A AU2901997 A AU 2901997A AU 2901997 A AU2901997 A AU 2901997A
Authority
AU
Australia
Prior art keywords
preparation
containing same
vaccine containing
immunogenic complex
immunogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU29019/97A
Other versions
AU733845B2 (en
Inventor
Hans Binz
Jean-Francois Haeuw
Stefan Svenson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Publication of AU2901997A publication Critical patent/AU2901997A/en
Application granted granted Critical
Publication of AU733845B2 publication Critical patent/AU733845B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AU29019/97A 1996-05-07 1997-05-06 Immunogenic complex, use, method of preparation thereof and vaccine containing same Ceased AU733845B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR96/05692 1996-05-07
FR9605692A FR2748476B1 (en) 1996-05-07 1996-05-07 IMMUNOGENIC COMPLEX, ITS USE, ITS PREPARATION METHOD AND VACCINE CONTAINING THE SAME
PCT/FR1997/000800 WO1997041888A1 (en) 1996-05-07 1997-05-06 Immunogenic complex, use, method of preparation thereof and vaccine containing same

Publications (2)

Publication Number Publication Date
AU2901997A true AU2901997A (en) 1997-11-26
AU733845B2 AU733845B2 (en) 2001-05-31

Family

ID=9491907

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29019/97A Ceased AU733845B2 (en) 1996-05-07 1997-05-06 Immunogenic complex, use, method of preparation thereof and vaccine containing same

Country Status (9)

Country Link
EP (1) EP0914152A1 (en)
JP (1) JP2000509707A (en)
CN (1) CN1221348A (en)
AU (1) AU733845B2 (en)
BR (1) BR9708979A (en)
CA (1) CA2254084A1 (en)
FR (1) FR2748476B1 (en)
NZ (1) NZ332809A (en)
WO (1) WO1997041888A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2776521B1 (en) * 1998-03-27 2000-12-15 Pf Medicament USE OF P40 ACTIVE CONJUGATES BY NASAL
FR2785542B1 (en) * 1998-11-06 2001-02-09 Pf Medicament USE OF AN ENTEROMACTERY OmpA PROTEIN FOR THE SPECIFIC TARGETING OF A BIOLOGICALLY ACTIVE SUBSTANCE THAT IS ASSOCIATED WITH CELLS PRESENTING ANTIGENS SUCH AS HUMAN DENDRITIC CELLS
US6146902A (en) * 1998-12-29 2000-11-14 Aventis Pasteur, Inc. Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
FR2789588B1 (en) * 1999-02-17 2001-05-04 Pf Medicament USE OF AN OMPA ENTEROBACTERIA PROTEIN ASSOCIATED WITH AN ANTIGEN IN A PHARMACEUTICAL COMPOSITION FOR GENERATING OR INCREASING ANTIVIRAL, PEST CONTROL OR ANTITUMOR CYTOTOXIC RESPONSE
FR2789902A1 (en) * 1999-02-24 2000-08-25 Pf Medicament Use of enterobacterial outer membrane protein as immunogenic carrier, particularly for contraceptive and anti-cancer vaccines, provides strong humoral response
FR2790959B1 (en) * 1999-03-15 2003-06-27 Pf Medicament USE OF BACTERIAL MEMBRANARY FRACTIONS WITH ADJUVANT EFFECT, THEIR PREPARATION METHODS AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
FR2828106A1 (en) * 2001-08-02 2003-02-07 Pf Medicament Composition containing peptide from low molecular weight outer membrane protein, useful for preparing vaccines against infections or cancer
JP5286089B2 (en) * 2006-01-13 2013-09-11 バクスター・インターナショナル・インコーポレイテッド Method for purifying polysaccharides
CN107184972B (en) * 2017-06-20 2020-12-01 康希诺生物股份公司 A kind of Mycobacterium tuberculosis OS-tb oligosaccharide conjugate and its preparation method and application

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1331355C (en) * 1986-04-21 1994-08-09 Bioenterprises Pty. Ltd Immunopotentation
FR2682388B1 (en) * 1991-10-10 1995-06-09 Pasteur Merieux Serums Vacc PROCESS FOR THE PREPARATION OF AN OLIGOSIDE BY DEPOLYMERIZATION OF A POLYOSIDE DERIVED FROM A PATHOGENIC AGENT, OLIGOSIDE THUS OBTAINED AND ITS USE IN PARTICULAR AS A VACCINE AGENT.
US6153406A (en) * 1993-07-23 2000-11-28 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane protein P2 from Haemophilus influenzae type B
FR2718452B1 (en) * 1994-04-06 1996-06-28 Pf Medicament Element of immunogen, immunogenic agent, pharmaceutical composition and method of preparation.
FR2726472B1 (en) * 1994-11-07 1997-01-31 Pf Medicament CARRIER WITH ADJUVANT EFFECT, IMMUNOGENIC COMPLEX CONTAINING THE SAME, PREPARATION METHOD THEREOF, NUCLEOTIDE SEQUENCE AND VACCINE
FR2726471B1 (en) * 1994-11-07 1997-01-31 Pf Medicament PROCESS FOR IMPROVING THE IMMUNOGENICITY OF AN IMMUNOGENIC COMPOUND OR A HAPTENA AND APPLICATION TO THE PREPARATION OF VACCINES

Also Published As

Publication number Publication date
AU733845B2 (en) 2001-05-31
NZ332809A (en) 2000-05-26
EP0914152A1 (en) 1999-05-12
WO1997041888A1 (en) 1997-11-13
BR9708979A (en) 1999-08-03
JP2000509707A (en) 2000-08-02
FR2748476B1 (en) 1998-08-14
FR2748476A1 (en) 1997-11-14
CA2254084A1 (en) 1997-11-13
CN1221348A (en) 1999-06-30

Similar Documents

Publication Publication Date Title
AU654119B2 (en) Isoxazolines, method of preparation thereof, and their use as plant-protection agents
AU1108695A (en) Aza-4-iminoquinolines, methods of preparing them and their use
AU2071097A (en) Cannula and method of manufacture and use
AU4978097A (en) Catalyst and method of preparation
AU4913097A (en) Nucleic acid vaccines against rickettsial diseases and methods of use
AU3402197A (en) Clear cosmetic sticks and process for its preparation
AU2524497A (en) Size composition, method for its preparation, and use thereof
EP0756636A4 (en) Chondroitinases i and ii, methods of preparation, and use thereof
AU2446495A (en) Naphthalene derivatives, method of preparation and use
AU4018897A (en) Novel 3,4-diaryloxazolone derivatives, methods of preparation and therapeutic uses thereof
AU5175798A (en) Membrane and methods of preparing and using same
AU5168496A (en) Butyryl-tyrosinyl spermine, analogs thereof and methods of preparing and using same
AU2901997A (en) Immunogenic complex, use, method of preparation thereof and vaccine containing same
AU5218398A (en) Compositions for treating soils, method of preparation and use thereof
HUP9802419A3 (en) Antigenic preparations, process for preparation and uses thereof
GR3033842T3 (en) New triazolopurines, method of preparing them and their use as drugs
AU3473695A (en) Novel 4-aminopyridazines, method of preparing them and drugs containing these compounds
AU1314995A (en) Aminosulphonyl-phenyl-1h-pyrrole derivatives, method of their preparation and their use
AU4450696A (en) Enhanced immunogenic vaccine
AU2030197A (en) 2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof
PL311838A1 (en) Novel derivatives of thienopyridone, method of obtaining them as well as pharmaceutical preparation and method of obtaining same
AU3552797A (en) Vaccine preparations
AU734276C (en) Aryloxypropanolamine derivatives, method of preparation and applications thereof
AU7135996A (en) Oxazolidin-2-one derivatives, preparation method therefor and therapeutical use thereof
AU5219798A (en) Gpi-ceruloplasmin, analogs thereof, and methods of use

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired